Suvretta Capital Management, LLC Oric Pharmaceuticals, Inc. Transaction History

Suvretta Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$4.95 - $8.4 $6.98 Million - $11.8 Million	-1,409,719 Reduced 74.09%	492,924 $3.83 Million
Q3 2022 Nov 14, 2022	BUY	$3.15 - $5.24 $2.02 Million - $3.35 Million	640,179 Added 50.71%	1,902,643 $6.09 Million
Q2 2022 Aug 15, 2022	BUY	$2.7 - $7.07 $2.22 Million - $5.81 Million	821,768 Added 186.47%	1,262,464 $5.66 Million
Q4 2021 Feb 14, 2022	BUY	$12.01 - $20.3 $3.5 Million - $5.92 Million	291,596 Added 195.57%	440,696 $6.48 Million
Q3 2021 Nov 15, 2021	BUY	$15.9 - $25.22 $2.37 Million - $3.76 Million	149,100 New	149,100 $3.12 Million
Q1 2021 May 17, 2021	SELL	$23.67 - $36.85 $5.99 Million - $9.32 Million	-252,910 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$20.32 - $39.8 $5.14 Million - $10.1 Million	252,910 New	252,910 $8.56 Million
Q3 2020 Nov 16, 2020	SELL	$19.5 - $31.26 $1.49 Million - $2.39 Million	-76,432 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$25.68 - $38.12 $1.96 Million - $2.91 Million	76,432 New	76,432 $2.58 Million

124

66.6M

7.8K

700

Ticker ORIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,576,700
Market Cap $336M
Description
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...

Get notified when there are updates to the investment portfolio of Suvretta Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Suvretta Capital Management, LLC with notifications on news.